Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1202068036

Citations Report

Citations Report - Journal of Leukemia [386 Articles]

The articles published in Journal of Leukemia have been cited 386 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Leukemia.

Lipowicz M, Garcia A (2015)Handheld Device Adapted to Smartphone Cameras for the Measurement of Sodium Ion Concentrations at Saliva-Relevant Levels via Fluorescence. Bioengineering.2:122-38.

Babu KL, Mathew J, Doddamani GM, Narasimhaiah JK, Naik LR, et al. (2016) Oral health of children with acute lymphoblastic leukemia: A review. Journal of Orofacial Sciences.8:3.

Padhy J, Lakshmi KA. Research and Reviews: Journal of Pharmacognosy and Phytochemistry.

Shukla A, Cutucache CE, Sutton GL, Pitner MA, Rai K,et al.(2016) Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model. Experimental hematology.44:30-37.

Bécue A (2016) Emerging fields in fingermark (meta) detection–a critical review. Analytical Methods.8:7983-8003.

Bécue A (2016)Emerging fields in fingermark (meta) detection–a critical review. Analytical Methods.8 :7983-8003.

Lapierre M, Castet-Nicolas A, Gitenay D, Jalaguier S, Teyssier C, et al. (2015) Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia. Journal of hematology & oncology.8:20.

Xu J, Zhou P, Wang W, Sun A, Guo F (2014) RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow. Journal of Molecular Medicine.92:77-92.

Hallermann C, Atzpodien J, Schulze PD (2010) Maligne Lymphome der Haut–Update zu Diagnostik und Therapie. best practice onkologie. 25: 4-21.

Argudo Martínez DC. Utilidad de la expresión del marcador inmunohistoquimico ALK en pacientes con diagnóstico de linfoma no Hodgkin (Doctoral dissertation, PUCE).

Hallermann C, Niermann C, Fluck M, Fischedick AR, Schulze HJ, et al. (2011) Maligne Lymphome der Haut. Der Hautarzt. 62: 947-958.

Barth BM, Keasey NR, Wang X, Shanmugavelandy SS, Rampal R,et al. (2014)Engraftment of Human Primary Acute Myeloid Leukemia Defined by Integrated Genetic Profiling in NOD/SCID/IL2rγnull Mice for Preclinical Ceramide-Based Therapeutic Evaluation.J Leuk. 2:2.

Morad SA, Davis TS, Kester M, Loughran TP, Cabot MC, et al.(2015) Dynamics of ceramide generation and metabolism in response to fenretinide–Diversity within and among leukemia. Leukemia research.39:1071-1078.

Sun Z, Wang Y, Han X, Zhao X, Peng Y, et al.(2015) miR-150 inhibits terminal erythroid proliferation and differentiation. Oncotarget.6:43033.

Zhang Z, Zhang T, Zhou Y, Wei X, Zhu J, et al.(2015) Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling. Cellular Physiology and Biochemistry.35:1643-53.

Rochette L, Gudjoncik A, Guenancia C, Zeller M, Cottin Y,et al. (2015) The iron-regulatory hormone hepcidin: a possible therapeutic target?. Pharmacology & therapeutics.28:35-52.

Grosicki S. (2014) Zależna od terapii ostra białaczka szpikowa—czynniki ryzyka i leczenie. Hematologia. 5:136-44.

Varella-garcia M, Franklin WA, Camidge DR. Do More With Less.

Aisner DL, Rumery MD, Merrick DT, Kondo KL, et al.(2016) Do More With Less: Tips and Techniques for Maximizing Small Biopsy and Cytology Specimens for Molecular and Ancillary Testing: The University of Colorado Experience. Archives of Pathology & Laboratory Medicine. 140:1206-20.

Bubolz AM, Weissinger SE, Stenzinger A, Arndt A, Steinestel K, et al.(2014) Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget. 5:4060.

Relevant Topics

Top